Connor, Clark & Lunn Investment Management Ltd. Cv Rx, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$22 Billion
Q2 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 10, 2023	BUY	$8.57 - $15.44 $209,879 - $378,125	24,490 New	24,490 $378,000

Others Institutions Holding CVRX

# of Institutions

Shares Held

13.5M

Call Options Held

49.9K

Put Options Held

2.1K

Johnson & Johnson New Brunswick, NJ

4.1M
Shares

$35.4 Million
16.99% of portfolio
Nea Management Company, LLC Timonium, MD

2.37M
Shares

$20.5 Million
2.68% of portfolio
Black Rock Inc. New York, NY

876K
Shares

$7.56 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

664K
Shares

$5.73 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

587K
Shares

$5.07 Million
0.71% of portfolio

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $178M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account